tanshinone ii a has been researched along with N-[(1R)-2-(tert-butylamino)-2-oxo-1-(3-pyridinyl)ethyl]-N-(4-tert-butylphenyl)-2-furancarboxamide in 2 studies
| Studies (tanshinone ii a) | Trials (tanshinone ii a) | Recent Studies (post-2010) (tanshinone ii a) | Studies (N-[(1R)-2-(tert-butylamino)-2-oxo-1-(3-pyridinyl)ethyl]-N-(4-tert-butylphenyl)-2-furancarboxamide) | Trials (N-[(1R)-2-(tert-butylamino)-2-oxo-1-(3-pyridinyl)ethyl]-N-(4-tert-butylphenyl)-2-furancarboxamide) | Recent Studies (post-2010) (N-[(1R)-2-(tert-butylamino)-2-oxo-1-(3-pyridinyl)ethyl]-N-(4-tert-butylphenyl)-2-furancarboxamide) |
|---|---|---|---|---|---|
| 61 | 0 | 41 | 8 | 0 | 8 |
| Protein | Taxonomy | tanshinone ii a (IC50) | N-[(1R)-2-(tert-butylamino)-2-oxo-1-(3-pyridinyl)ethyl]-N-(4-tert-butylphenyl)-2-furancarboxamide (IC50) |
|---|---|---|---|
| Spike glycoprotein | Betacoronavirus England 1 | 1.5 | |
| Replicase polyprotein 1ab | Betacoronavirus England 1 | 1.5 | |
| Transmembrane protease serine 2 | Homo sapiens (human) | 1.5 | |
| Procathepsin L | Homo sapiens (human) | 1.5 | |
| Replicase polyprotein 1a | Severe acute respiratory syndrome-related coronavirus | 1.5 | |
| Replicase polyprotein 1ab | Human coronavirus 229E | 1.5 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 2.325 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 2.6 | |
| Spike glycoprotein | Severe acute respiratory syndrome-related coronavirus | 1.5 | |
| Angiotensin-converting enzyme 2 | Homo sapiens (human) | 1.5 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Easwaran, M; Manickam, M; Pillaiyar, T; Wendt, LL | 1 |
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
1 review(s) available for tanshinone ii a and N-[(1R)-2-(tert-butylamino)-2-oxo-1-(3-pyridinyl)ethyl]-N-(4-tert-butylphenyl)-2-furancarboxamide
| Article | Year |
|---|---|
The recent outbreaks of human coronaviruses: A medicinal chemistry perspective.
Topics: Antiviral Agents; Chemistry, Pharmaceutical; COVID-19; Disease Outbreaks; Drug Repositioning; Humans; Virus Internalization | 2021 |
1 other study(ies) available for tanshinone ii a and N-[(1R)-2-(tert-butylamino)-2-oxo-1-(3-pyridinyl)ethyl]-N-(4-tert-butylphenyl)-2-furancarboxamide
| Article | Year |
|---|---|
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |